| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 284 |
| 1 | ECULIZUMAB | 135 |
| 2 | CYCLOPHOSPHAMIDE | 105 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 105 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 105 |
| 5 | DEFERASIROX | 104 |
| 6 | METHOTREXATE SODIUM | 98 |
| 7 | METHOTREXATE | 97 |
| 8 | CYCLOSPORINE | 85 |
| 9 | ACYCLOVIR | 84 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LARONIDASE | 38 | 0.0092 |
| 1 | DASATINIB | 69 | 0.0074 |
| 2 | PONATINIB HYDROCHLORIDE | 37 | 0.0071 |
| 3 | VENETOCLAX | 284 | 0.0045 |
| 4 | DEFERASIROX | 104 | 0.0039 |
| 5 | ECULIZUMAB | 135 | 0.0025 |
| 6 | IMATINIB MESYLATE | 44 | 0.0016 |
| 7 | FLUDARABINE PHOSPHATE | 58 | 0.0015 |
| 8 | VALPROATE SODIUM | 29 | 0.0014 |
| 9 | AZACITIDINE | 36 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 284 |
| 1 | Corticosteroid [EPC] | 177 |
| 2 | Kinase Inhibitor [EPC] | 153 |
| 3 | Alkylating Drug [EPC] | 141 |
| 4 | Complement Inhibitor [EPC] | 138 |
| 5 | Iron Chelator [EPC] | 111 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 101 |
| 7 | Azole Antifungal [EPC] | 98 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 97 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 86 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 83 | 0.0142 |
| 1 | Interferon gamma [EPC] | 15 | 0.0106 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 22 | 0.0068 |
| 3 | BCL-2 Inhibitor [EPC] | 284 | 0.0045 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 57 | 0.0043 |
| 5 | Iron Chelator [EPC] | 111 | 0.0038 |
| 6 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 7 | CD22-directed Immunoconjugate [EPC] | 8 | 0.0027 |
| 8 | Complement Inhibitor [EPC] | 138 | 0.0025 |
| 9 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 6 | 0.0024 |